Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 4Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 522Neoplasms 470Carcinoma, Non-Small-Cell Lung 393Prostatic Neoplasms 302Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 217Ovarian Neoplasms 198Leukemia, Myeloid, Acute 194Pancreatic Neoplasms 185Multiple Myeloma 172Squamous Cell Carcinoma of Head and Neck 133Recurrence 132Stomach Neoplasms 129Brain Neoplasms 126Melanoma 123Carcinoma, Hepatocellular 123Endometrial Neoplasms 120Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Hematologic Neoplasms 99Head and Neck Neoplasms 97Carcinoma, Renal Cell 96Lymphoma 93Urinary Bladder Neoplasms 90Sarcoma 90Glioma 88Lymphoma, Large B-Cell, Diffuse 81Small Cell Lung Carcinoma 80

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Treatment Adherence and Compliance × 90 days × Clear all
NCT07118683 2026-05-22

BRAVO

Hospital Alemão Oswaldo Cruz

Recruiting
743 enrolled

Treatment Adherence and Compliance, Acquired Immunodeficiency Syndrome, Cardiovascular Diseases, Cerebrovascular Disorders, Neoplasms, Respiratory Tract Diseases, Renal Insufficiency, Chronic

NCT04740697 2026-04-20

EUTACAM

Institut Claudius Regaud

Phase NA Recruiting
200 enrolled
Breast

Treatment Adherence and Compliance, Breast Neoplasms

NCT07524829 2026-04-13

Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

Azienda Sanitaria Locale di Asti

Phase NA Recruiting
124 enrolled
Breast

Treatment Adherence and Compliance, Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06856902 2026-04-01

BEAMER

Technical University of Madrid

Phase NA Recruiting
3,100 enrolled

Treatment Adherence and Compliance, Cardiovascular Diseases, Neoplasms, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡